-Outlook Dengue continued to spread in the capital with 38 more people testing positive for the mosquito-borne disease, taking the total number of cases to 1,584 this season. Thirty-seven of the fresh cases were reported from East, South and North Delhi Corporations while one originated from outside the capital. So far, four persons have died in the capital due to dengue. Of the 1,584 cases, 12 cases originated from outside the city. South Delhi...
More »SEARCH RESULT
Number of Dengue Cases in Delhi Inching Closer to 1000
-Outlook Dengue cases in the capital inched closer towards touching the 1,000-mark with 36 people testing positive for the mosquito-borne disease today, taking the total number of cases this season to 985. All the 36 cases were reported from three Municipal Corporations, with the maximum number of cases coming from Shah (North) zone. Two children have so far succumbed to dengue ever since the disease began spreading in the capital early this month. South...
More »Driving the wrong way on road safety -G Ananthakrishnan
-The Hindu India’s roads are deadlier than ever. The high rates of death and disability expose the lack of an organised system of traffic management and safety. Road safety is no one’s responsibility. It is time to make someone accountable. On the final day of this year’s ‘puja’ season in Chennai, a particular roadside temple near the iconic Central Railway Station had the long annual line of vehicles — vans, tempos, taxis,...
More »Dengue still retains its deadly bite -R Prasad
-The Hindu Vaccine’s overall efficacy in a recent trial is ‘lower than expected’ The just concluded Phase IIb (proof-of-concept) dengue vaccine trial against all the four virus types (serotypes) that cause dengue has not only shown an unexpectedly low efficacy of 30.2 per cent but has also challenged many well-established hypotheses and ideas. The trial was conducted in about 4,000 children in the age group 4 and 11 in the dengue endemic district...
More »How to usher in vaccinnovation in India by MK Bhan
-The Economic Times Vaccines are a true gift of science to humanity. In developing countries, prevention is better than cure. Vaccines have a great track record of safety and efficacy and they are amongst the most cost-effective products, which even the poor have access to due to effective systems of procurement and delivery. India's contribution in the vaccine arena is noteworthy. The primary reason behind the country's vaccine success story is...
More »